These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17587821)

  • 21. Inflammatory cytokines augments TGF-beta1-induced epithelial-mesenchymal transition in A549 cells by up-regulating TbetaR-I.
    Liu X
    Cell Motil Cytoskeleton; 2008 Dec; 65(12):935-44. PubMed ID: 18792103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of hepatocyte nuclear factor-4alpha and its role in regulation of gene expression by TGF-beta in mammary epithelial cells.
    Ishikawa F; Nose K; Shibanuma M
    Exp Cell Res; 2008 Jun; 314(10):2131-40. PubMed ID: 18433744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complementary analysis of microRNA and mRNA expression during phorbol 12-myristate 13-acetate (TPA)-induced differentiation of HL-60 cells.
    Chen A; Luo M; Yuan G; Yu J; Deng T; Zhang L; Zhou Y; Mitchelson K; Cheng J
    Biotechnol Lett; 2008 Dec; 30(12):2045-52. PubMed ID: 18648749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
    Bandres E; Bitarte N; Arias F; Agorreta J; Fortes P; Agirre X; Zarate R; Diaz-Gonzalez JA; Ramirez N; Sola JJ; Jimenez P; Rodriguez J; Garcia-Foncillas J
    Clin Cancer Res; 2009 Apr; 15(7):2281-90. PubMed ID: 19318487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430.
    Choi WY; Giraldez AJ; Schier AF
    Science; 2007 Oct; 318(5848):271-4. PubMed ID: 17761850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.
    Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P
    Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-31 is a positive modulator of endothelial-mesenchymal transition and associated secretory phenotype induced by TGF-β.
    Katsura A; Suzuki HI; Ueno T; Mihira H; Yamazaki T; Yasuda T; Watabe T; Mano H; Yamada Y; Miyazono K
    Genes Cells; 2016 Jan; 21(1):99-116. PubMed ID: 26663584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The microRNA network and tumor metastasis.
    Zhang H; Li Y; Lai M
    Oncogene; 2010 Feb; 29(7):937-48. PubMed ID: 19935707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta.
    Zavadil J; Bitzer M; Liang D; Yang YC; Massimi A; Kneitz S; Piek E; Bottinger EP
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6686-91. PubMed ID: 11390996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA regulatory networks in idiopathic pulmonary fibrosis.
    Pandit KV; Milosevic J
    Biochem Cell Biol; 2015 Apr; 93(2):129-37. PubMed ID: 25557625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs, transforming growth factor beta-1, and tissue fibrosis.
    Bowen T; Jenkins RH; Fraser DJ
    J Pathol; 2013 Jan; 229(2):274-85. PubMed ID: 23042530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Riboregulators in kidney development and function.
    Karolina DS; Wintour EM; Bertram J; Jeyaseelan K
    Biochimie; 2010 Mar; 92(3):217-25. PubMed ID: 20045037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mesenchyme in cancer therapy as a target tumor component, effector cell modality and cytokine expression vehicle.
    Zipori D
    Cancer Metastasis Rev; 2006 Sep; 25(3):459-67. PubMed ID: 17001513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatiotemporal dynamics of microRNA during epithelial collective cell migration.
    Dean ZS; Riahi R; Wong PK
    Biomaterials; 2015 Jan; 37():156-63. PubMed ID: 25453946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA in acute myeloid leukemia.
    Ritchie WJ; Flamant S; Rasko JE
    N Engl J Med; 2008 Aug; 359(6):653; author reply 653-4. PubMed ID: 18687650
    [No Abstract]   [Full Text] [Related]  

  • 36. MicroRNA: microRNAs reach out into dendrites.
    Tai HC; Schuman EM
    Curr Biol; 2006 Feb; 16(4):R121-3. PubMed ID: 16488859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-203 represses selection and expansion of oncogenic Hras transformed tumor initiating cells.
    Riemondy K; Wang XJ; Torchia EC; Roop DR; Yi R
    Elife; 2015 Jul; 4():. PubMed ID: 26203562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New TGF-beta and Ras crosstalk in EMT.
    Zavadil J
    Cell Cycle; 2009 Jan; 8(2):184. PubMed ID: 19164907
    [No Abstract]   [Full Text] [Related]  

  • 39. Endothelial-to-mesenchymal transition and microRNA-21: the game is on again.
    Cavarretta E; Latronico MV; Condorelli G
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):165-6. PubMed ID: 22258897
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif.
    Hamilton MP; Rajapakshe K; Hartig SM; Reva B; McLellan MD; Kandoth C; Ding L; Zack TI; Gunaratne PH; Wheeler DA; Coarfa C; McGuire SE
    Nat Commun; 2013; 4():2730. PubMed ID: 24220575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.